Status:
UNKNOWN
Evaluation of Consumption of Sevoflurane in Chronic Obstructive Pulmonary Disease Patients
Lead Sponsor:
Employee's State Insurance Corporation, New Delhi
Collaborating Sponsors:
Medtronic Spine LLC
Conditions:
Chronic Obstructive Pulmonary Disease
Eligibility:
All Genders
Brief Summary
All the Patients undergoing General Anesthesia and the patients who are having Chronic Obstructive Pulmonary Disease will be considered for this study. The Volume consumption of Sevoflurane will be st...
Detailed Description
Chronic Obstructive pulmonary disease is known to escalate the consumption of Inhalation Agents in General Anesthesia. Hence the Data to Collect the Official Record
Eligibility Criteria
Inclusion
- Both Sex All Age Group Patient willing to give consent COPD patient
Exclusion
- Not willing to give consent Cancerous Lung Lung Lobectomy
Key Trial Info
Start Date :
January 1 2024
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
March 30 2025
Estimated Enrollment :
45 Patients enrolled
Trial Details
Trial ID
NCT06108973
Start Date
January 1 2024
End Date
March 30 2025
Last Update
October 31 2023
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.